We are harnessing the power of nature to fight bacterial infections
Bacteriophages, often referred to as phages, are the weapon of the future in the fight against bacterial pathogens. These viruses possess a remarkable ability to target and infect specific bacteria, making them highly selective agents of destruction. With a genetic material, either DNA or RNA, enclosed within a protective protein coat, bacteriophages seek out their bacterial hosts and inject their genetic material into them. Once inside, they hijack the bacterial machinery, forcing it to produce more phages while disrupting critical bacterial functions. This relentless assault ultimately culminates in the bursting of the bacterial cell, releasing a new generation of phages to seek out and destroy more bacteria. Harnessing the power of bacteriophages offers a promising approach to combatting bacterial diseases such as AHPND in shrimp, revolutionizing disease control strategies and paving the way for a safer and more sustainable future.
A team of passionate scientists, innovators, and visionaries united by a common goal—to revolutionize disease control in aquaculture. At HEDROS, we believe that by combining our expertise in biotechnology and our deep understanding of bacteriophages, we can make a profound impact on the health and sustainability of aquatic ecosystems. Our multidisciplinary team works tirelessly to develop advanced solutions that combat bacterial diseases, such as AHPND in shrimp, while minimizing the use of antibiotics and preserving the delicate balance of aquatic environments. With our unwavering commitment to research, innovation, and sustainable practices, we strive to empower the aquaculture industry with effective, eco-friendly tools that ensure the well-being of aquatic species and support the global demand for safe and healthy seafood. Together, we are Hedros, driving positive change in aquaculture and shaping a better future for our planet.
Our biotech startup offers a groundbreaking solution to combat AHPND in shrimp. We have developed a proprietary formulation of highly targeted bacteriophages specifically engineered to eradicate the bacteria responsible for AHPND. Our solution involves a meticulous process of identifying and isolating bacteriophages that exhibit a high affinity for the pathogenic bacteria while sparing beneficial bacteria. These bacteriophages are then formulated into an effective delivery system, ensuring their targeted delivery to the affected shrimp populations. By leveraging the natural predatory nature of bacteriophages, we provide a precise and environmentally friendly alternative to traditional antibiotics. Our solution holds immense potential in mitigating the devastating impact of AHPND, safeguarding shrimp populations, and supporting sustainable aquaculture practices.